Literature DB >> 34168067

The Impact of Obesity on Disease Severity and Outcomes Among Hospitalized Children With COVID-19.

Sandeep Tripathi1, Amy L Christison2, Emily Levy3, Jeremy McGravery4, Aysun Tekin3, Dawn Bolliger4, Vishakha K Kumar5, Vikas Bansal3, Kathleen Chiotos6, Katja M Gist7, Heda R Dapul8, Utpal S Bhalala9, Varsha P Gharpure10, Julia A Heneghan11, Neha Gupta12, Erica C Bjornstad13, Vicki L Montgomery14, Allan Walkey15, Rahul Kashyap3, Grace M Arteaga.   

Abstract

OBJECTIVE: To describe the impact of obesity on disease severity and outcomes of coronavirus disease 2019 (COVID-19) among hospitalized children.
METHODS: This retrospective cohort study from the Society of Critical Care Medicine Viral Respiratory Illness Universal Study registry included all children hospitalized with COVID-19 from March 2020 to January 2021. Obesity was defined by Centers for Disease Control and Prevention BMI or World Health Organization weight for length criteria. Critical illness definition was adapted from National Institutes of Health criteria of critical COVID. Multivariate mixed logistic and linear regression was performed to calculate the adjusted odds ratio of critical illness and the adjusted impact of obesity on hospital length of stay.
RESULTS: Data from 795 patients (96.4% United States) from 45 sites were analyzed, including 251 (31.5%) with obesity and 544 (68.5%) without. A higher proportion of patients with obesity were adolescents, of Hispanic ethnicity, and had other comorbidities. Those with obesity were also more likely to be diagnosed with multisystem inflammatory syndrome in children (35.7% vs 28.1%, P = .04) and had higher ICU admission rates (57% vs 44%, P < .01) with more critical illness (30.3% vs 18.3%, P < .01). Obesity had more impact on acute COVID-19 severity than on multisystem inflammatory syndrome in children presentation. The adjusted odds ratio for critical illness with obesity was 3.11 (95% confidence interval: 1.8-5.3). Patients with obesity had longer adjusted length of stay (exponentiated parameter estimate 1.3; 95% confidence interval: 1.1-1.5) compared with patients without obesity but did not have increased mortality risk due to COVID-19 (2.4% vs 1.5%, P = .38).
CONCLUSION: In a large, multicenter cohort, a high proportion of hospitalized children from COVID-19 had obesity as comorbidity. Furthermore, obesity had a significant independent association with critical illness.
Copyright © 2021 by the American Academy of Pediatrics.

Entities:  

Mesh:

Year:  2021        PMID: 34168067     DOI: 10.1542/hpeds.2021-006087

Source DB:  PubMed          Journal:  Hosp Pediatr        ISSN: 2154-1671


  8 in total

1.  Association of Early Steroid Administration With Outcomes of Children Hospitalized for COVID-19 Without Multisystem Inflammatory Syndrome in Children.

Authors:  Sandeep Tripathi; Meghana Nadiger; Jeremy S McGarvey; Aaron A Harthan; Monica Lombardo; Varsha P Gharpure; Nicholas Perkins; Kathleen Chiotos; Imran A Sayed; Erica C Bjornstad; Utpal S Bhalala; Umamaheswara Raju; Aaron S Miller; Heda Dapul; Vicki Montgomery; Karen Boman; Grace M Arteaga; Vikas Bansal; Neha Deo; Aysun Tekin; Ognjen Gajic; Vishakha K Kumar; Rahul Kashyap; Allan J Walkey
Journal:  JAMA Pediatr       Date:  2022-10-03       Impact factor: 26.796

2.  Impact of environmental and individual factors on COVID-19 mortality in children and adolescents in Mexico: An observational study.

Authors:  Carlos Sanchez-Piedra; Ana-Estela Gamiño-Arroyo; Copytzy Cruz-Cruz; Francisco-Javier Prado-Galbarro
Journal:  Lancet Reg Health Am       Date:  2022-01-20

3.  Comparison of the clinical characteristics and outcomes of COVID-19 in children before and after the emergence of Delta variant of concern in Japan.

Authors:  Kensuke Shoji; Takayuki Akiyama; Shinya Tsuzuki; Nobuaki Matsunaga; Yusuke Asai; Setsuko Suzuki; Noriko Iwamoto; Takanori Funaki; Norio Ohmagari
Journal:  J Infect Chemother       Date:  2022-01-20       Impact factor: 2.065

4.  Obesity and clinical outcomes in COVID-19 patients without comorbidities, a post-hoc analysis from ORCHID trial.

Authors:  Peng Yu; Ziqi Tan; Zhangwang Li; Yi Xu; Jing Zhang; Panpan Xia; Xiaoyi Tang; Jianyong Ma; Minxuan Xu; Xiao Liu; Yunfeng Shen
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-29       Impact factor: 6.055

5.  A Case Report of Postinfectious Bronchiolitis Obliterans After Coronavirus Disease 2019 in a 10-Year-Old Child.

Authors:  Sungsu Jung; Kyo Jin Jo; Miran Lee; Jae-Yeon Hwang; Su Eun Park
Journal:  J Korean Med Sci       Date:  2022-08-08       Impact factor: 5.354

6.  The Role of Childhood Obesity in Acute Presentations and Outcomes of Hospitalized COVID-19 Patients.

Authors:  Tyler Tolopka; Joshua Kuehne; Kiran Mainali; Morgan Beebe; Melinda Garcia; Mohammed Salameh; Rosario Ocampo; Utpal Bhalala
Journal:  Cureus       Date:  2022-09-07

Review 7.  COVID-19 Pandemic as Risk Factors for Excessive Weight Gain in Pediatrics: The Role of Changes in Nutrition Behavior. A Narrative Review.

Authors:  Hellas Cena; Lauren Fiechtner; Alessandra Vincenti; Vittoria Carlotta Magenes; Rachele De Giuseppe; Matteo Manuelli; Gian Vincenzo Zuccotti; Valeria Calcaterra
Journal:  Nutrients       Date:  2021-11-26       Impact factor: 5.717

8.  How Comorbidities Affect Hospitalization from Influenza in the Pediatric Population.

Authors:  Sophia C Mylonakis; Evangelia K Mylona; Markos Kalligeros; Fadi Shehadeh; Philip A Chan; Eleftherios Mylonakis
Journal:  Int J Environ Res Public Health       Date:  2022-02-28       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.